TEMPORARY USE OF GLUCOSE SENSORS IN TYPE 1 DIABETES PATIENTS ON CONTINUOUS SUBCUTANEOUS INSULIN INFUSION

被引：0
|
作者：
Zivkovic, M. [1 ]
Petrovski, G. [1 ]
Stratrova, S. Shubeska [1 ,2 ]
机构：
[1] Univ Clin Endocrinol Diabet & Metab Disorders, Med Fac, Centar Insulin Pump & Sensor, Skopje, North Macedonia
[2] Univ Clin Endocrinol Diabet & Metab Disorders, Med Fac, Ctr Insulin Pump & Sensor, Skopje, North Macedonia
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2020年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
946
引用
收藏
页码：A147 / A147
页数：1
相关论文
共 50 条
  • [21] The Impact of Prolonged Use of Continuous Subcutaneous Insulin Infusion in the Control of Type-1 Diabetes
    Azevedo, Sergio
    Saraiva, Joana
    Caramelo, Francisco
    Fadiga, Lucia
    Barros, Luisa
    Baptista, Carla
    Melo, Miguel
    Gomes, Leonor
    Carrilho, Francisco
    ACTA MEDICA PORTUGUESA, 2019, 32 (01) : 17 - 24
  • [22] Better Postprandial Glucose Stability During Continuous Subcutaneous Infusion with Insulin Aspart Compared with Insulin Lispro in Patients with Type 1 Diabetes
    Di Bartolo, Paolo
    Pellicano, Francesca
    Scaramuzza, Antonio
    Sardu, Cipriana
    Casetti, Tino
    Bosi, Emanuele
    Miselli, Valerio
    Brandolini, Sara
    Fabbri, Tiziano
    Meandri, Piero
    Cannata, Francesco
    DIABETES TECHNOLOGY & THERAPEUTICS, 2008, 10 (06) : 495 - 498
  • [23] Blinded Continuous Glucose Monitoring During Yom Kippur Fasting in Patients With Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion Therapy
    Metzger, Muriel
    Lederhendler, Lisa
    Corcos, Asher
    DIABETES CARE, 2015, 38 (03) : E34 - E35
  • [24] Accuracy assessment of online glucose monitoring by a subcutaneous enzymatic glucose sensor during exercise in patients with type 1 diabetes treated by continuous subcutaneous insulin infusion
    Radermecker, R. -P.
    Fayolle, C.
    Brun, J. -F.
    Bringer, J.
    Renard, E.
    DIABETES & METABOLISM, 2013, 39 (03) : 258 - 262
  • [25] Nocturnal hypoglycemia is not inevitable in type 1 diabetes patients on continuous subcutaneous insulin infusion (CSII)
    Devries, J
    Masurel, N
    Poscia, A
    Heine, R
    DIABETES, 2003, 52 : A92 - A92
  • [26] Impact of continuous subcutaneous insulin infusion (CSII) therapy on retinopathy in patients with Type 1 diabetes
    Khan, I.
    Hopley, D.
    Glover, L.
    Bett, S.
    Young, S.
    Ratcliffe, J.
    Martin, P.
    Krishnan, S.
    Bharaj, H.
    Banerjee, M.
    DIABETIC MEDICINE, 2019, 36 : 73 - 73
  • [27] Retinopathy status in patients with Type 1 diabetes pre and post continuous subcutaneous insulin infusion
    May, C. J.
    Hamada, M.
    Shayovitz, V.
    Dyer, P.
    Teh, M.
    Karamat, A.
    Syed, A.
    DIABETIC MEDICINE, 2013, 30 : 183 - 183
  • [28] Management of cardiovascular risk factors in patients with Type 1 diabetes on continuous subcutaneous insulin infusion
    May, C. J.
    John, R.
    Syed, A.
    DIABETIC MEDICINE, 2013, 30 : 88 - 88
  • [29] Continuous subcutaneous insulin infusion in patients with diabetes mellitus
    Schiel, R
    THERAPEUTIC APHERESIS AND DIALYSIS, 2003, 7 (02) : 232 - 237
  • [30] Use of continuous glucose sensors in patients with type 1 diabetes running a marathon
    Press, M
    DIABETES, 2001, 50 : A484 - A484
12345